Your browser doesn't support javascript.
loading
Corticosteroid sensitization drives opioid addiction.
Carmack, Stephanie A; Vendruscolo, Janaina C M; Adrienne McGinn, M; Miranda-Barrientos, Jorge; Repunte-Canonigo, Vez; Bosse, Gabriel D; Mercatelli, Daniele; Giorgi, Federico M; Fu, Yu; Hinrich, Anthony J; Jodelka, Francine M; Ling, Karen; Messing, Robert O; Peterson, Randall T; Rigo, Frank; Edwards, Scott; Sanna, Pietro P; Morales, Marisela; Hastings, Michelle L; Koob, George F; Vendruscolo, Leandro F.
Afiliação
  • Carmack SA; Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD, USA.
  • Vendruscolo JCM; Center for Adaptive Systems of Brain-Body Interactions, George Mason University, Fairfax, VA, USA.
  • Adrienne McGinn M; Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD, USA.
  • Miranda-Barrientos J; Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD, USA.
  • Repunte-Canonigo V; Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD, USA.
  • Bosse GD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Mercatelli D; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
  • Giorgi FM; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Fu Y; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Hinrich AJ; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Jodelka FM; Center for Genetic Diseases, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
  • Ling K; Center for Genetic Diseases, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
  • Messing RO; Ionis Pharmaceuticals, Carlsbad, CA, USA.
  • Peterson RT; Waggoner Center for Alcohol and Addiction Research, Department of Neuroscience and Neurology, University of Texas, Austin, TX, USA.
  • Rigo F; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
  • Edwards S; Ionis Pharmaceuticals, Carlsbad, CA, USA.
  • Sanna PP; Department of Physiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
  • Morales M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
  • Hastings ML; Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD, USA.
  • Koob GF; Center for Genetic Diseases, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
  • Vendruscolo LF; Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institute of Health, Baltimore, MD, USA.
Mol Psychiatry ; 27(5): 2492-2501, 2022 05.
Article em En | MEDLINE | ID: mdl-35296810
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article